Trial Profile
Comparison of coasting with cabergoline administration for prevention of early severe Ovarian Hyper Stimulation Syndrome in Assisted Reproductive Technology cycles.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary) ; Chorionic gonadotropin; Progesterone
- Indications Ovarian hyperstimulation syndrome
- Focus Adverse reactions
- 14 Oct 2011 New trial record